Azenta, Inc. quarterly report, Q2 FY2014

Business Context and Reporting Period

The filing is a Form 10-Q for Brooks Automation, Inc. (the company identified in the filing; the request metadata references Azenta, Inc.) for the quarter and six months ended March 31, 2014, the second quarter of fiscal 2014. Brooks provides automation, vacuum, service, and life-science systems, with substantial exposure to cyclical semiconductor capital-equipment demand.

Granville-Phillips was classified as a discontinued operation after Brooks agreed to sell the business to MKS Instruments for $87.0 million in cash. Continuing-operations results exclude Granville-Phillips.

Financial Performance and Position

MetricThree months ended March 31, 2014Prior yearSix months ended March 31, 2014Prior year
Total revenue$125.9 million$109.5 million$243.0 million$201.0 million
Gross profit$44.3 million$33.1 million$85.2 million$59.4 million
Gross margin35.2%30.2%35.1%29.5%
Operating income (loss)$2.4 million$(3.2) million$3.9 million$(17.6) million
Net income (loss) attributable to Brooks$3.2 million$(0.5) million$6.6 million$(9.8) million
Diluted EPS$0.05$(0.01)$0.10$(0.15)
Operating cash flowNot separately providedNot separately provided$35.7 million$16.7 million
  • Revenue increased 15% in the quarter and 21% year to date. Product revenue rose to $102.5 million for the quarter and services revenue to $23.4 million.
  • Gross-margin expansion reflected lower material and warranty costs, higher production volumes, improved fixed-cost absorption, and prior-year acquisition inventory step-up charges.
  • Research and development expense increased to $12.5 million for the quarter and $25.0 million year to date. SG&A increased to $28.6 million and $54.8 million, respectively, including higher incentive compensation, stock-based compensation, and Matrical expenses.
  • At March 31, 2014, cash and cash equivalents were $85.3 million and marketable securities were $106.9 million, for total cash and marketable securities of $192.2 million.
  • Total assets were $767.2 million and total equity was $634.4 million. The company reported capital lease obligations of $8.5 million and no interest-bearing debt expense for the quarter.
  • The company paid $10.8 million of dividends during the first six months and declared a subsequent $0.08-per-share dividend payable June 27, 2014.

Material Changes Versus the Prior Comparable Period

  • Brooks Product Solutions revenue increased 14% in the quarter and 27% year to date, primarily from stronger semiconductor capital-equipment and industrial-market demand.
  • Brooks Global Services revenue increased 7% in the quarter and 9% year to date, driven mainly by semiconductor end-user and capital-equipment demand.
  • Brooks Life Science Systems revenue increased 38% in the quarter and 6% year to date. The Matrical acquisition contributed $2.1 million in quarterly revenue and $3.4 million year to date.
  • Segment operating income improved to $4.8 million in the quarter and $8.5 million year to date, compared with segment losses of $0.6 million and $8.1 million in the prior-year periods.
  • Restructuring charges declined to $0.8 million for the quarter and $1.5 million year to date, versus $0.8 million and $5.4 million, respectively, in the prior year.
  • Operating cash flow more than doubled year to date, benefiting substantially from a $13.4 million increase in deferred revenue, partly offset by a $6.1 million increase in accounts receivable.

Guidance, Outlook, Risks, and Unusual Items

  • Management stated that available resources should fund planned working capital and capital expenditures for the next twelve months, but noted that semiconductor-market cyclicality and broader economic uncertainty make longer-term liquidity needs difficult to predict.
  • Management expected the Granville-Phillips sale to close in the quarter ending June 30, 2014 and projected a pretax gain of $56 million to $58 million and an after-tax gain of $26 million to $28 million, subject to working-capital adjustments and closing conditions.
  • Granville-Phillips generated $7.5 million of quarterly revenue and $1.2 million of after-tax income, compared with $7.1 million and $2.7 million, respectively, in the prior-year quarter.
  • Polycold manufacturing outsourcing is expected to produce approximately $1.1 million of severance and retention charges, with the remaining amount to be recognized through fiscal 2014.
  • A $0.4 million impairment charge was recorded for the Celigo product line in the first quarter; the product line was sold in the second quarter without a material overall impact.
  • On April 30, 2014, Brooks acquired DMS Dynamic Micro Systems Semiconductor Equipment GmbH for $31.0 million, including approximately $16.0 million for repayment of DMS debt, subject to a working-capital adjustment.
  • The company had approximately $20.5 million of outstanding letters of credit, which could be called if contractual requirements are not met. Legal proceedings were not expected to have a material adverse effect, although outcomes remain uncertain.
  • Market risks include semiconductor-cycle exposure, foreign-currency movements, and interest-rate sensitivity. A hypothetical 10% foreign-exchange change was estimated to affect net income by approximately $0.9 million; a 100-basis-point interest-rate change was estimated to affect annual interest income by approximately $1.7 million.
  • The company had one customer representing 10% of quarterly revenue and 12% of year-to-date revenue, creating customer-concentration risk.

Investor Verification Items

  • Verify that the filing entity is Brooks Automation, Inc., despite the request metadata identifying Azenta, Inc.
  • Confirm completion, final proceeds, working-capital adjustments, tax effects, and realized gain from the Granville-Phillips divestiture.
  • Assess whether revenue and margin improvements are sustainable if semiconductor capital-equipment demand weakens.
  • Monitor restructuring execution, remaining Polycold charges, warranty exposure, inventory reserves, and the $1.6 million restructuring accrual payable within twelve months.
  • Evaluate the cash impact and purchase-price allocation of the subsequent DMS acquisition and the company’s continuing dividend policy.
  • Review deferred tax asset valuation allowances, ongoing tax audits, and the potential reduction of unrecognized tax benefits by $1.7 million to $2.8 million over the following twelve months.